Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on April 8, 2025
Privia Health to Report First Quarter 2025 Results on Thursday, May 8
GlobeNewswire
·
April 8, 2025
ARLINGTON, Va., April 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2025 before market open on Thursday, May 8, 2025. The press …
General Oncology Appoints Seasoned Biotech Executive Abid Ansari as Chief Financial Officer
GlobeNewswire
·
April 8, 2025
BOSTON, April 08, 2025 (GLOBE NEWSWIRE) -- General Oncology, Inc., a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class medicines for metastatic cancers, today announced the appointment of Abid Ansari as Chief Financial Officer …
International Association of Fire Fighters & Affiliates Launch ‘Fill the Boot’ Fundraisers Nationwide in Support of the Muscular Dystrophy Association throughout the Organization’s 75th Anniversary
GlobeNewswire
·
April 8, 2025
New York, April 08, 2025 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association (MDA) and the International Association of Fire Fighters (IAFF) are celebrating over 70 years of partnership by launching more than 1,500 ‘Fill the Boot’ fundraisers nationwide …
AMPS Raises the Bar on RBP with PriceDynamix: Delivering Elevated Member Advocacy, Smarter Savings, and Greater Accountability
GlobeNewswire
·
April 8, 2025
PHOENIX, April 08, 2025 (GLOBE NEWSWIRE) -- The healthcare industry has outgrown the outdated and rigid model of Reference-Based Pricing. AMPS, a leader in healthcare cost savings and advocacy, is raising the bar with PriceDynamix, a smarter, more …
The Broken Brown Egg and Progyny Announce the 2025 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building
GlobeNewswire
·
April 8, 2025
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, and The Broken Brown Egg, a nonprofit supporting BIPOC individuals and couples experiencing infertility, today …
CORRECTION: ProDentim
GlobeNewswire
·
April 8, 2025
In a release issued under the same headline on April 1, 2025 by ProDentim, please note that the headline has been edited from "ProDentim Reviews (DOCTOR WARNING): Dentists …
SELLAS Announces Positive Overall Survival in Cohort 3 from the Ongoing Phase 2 Trial of SLS009 in r/r AML
GlobeNewswire
·
April 8, 2025
- 8.9 Months Median Overall Survival (mOS) in Patients with AML-Myelodysplasia-Related Changes (AML-MRC) and 8.8 mOS in All Relapsed or Refractory to Venetoclax-Based Regimens Patients; Surpassing Historical Benchmark of 2.5 Months - - Overall Response …
Outlook Therapeutics® Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
GlobeNewswire
·
April 8, 2025
Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 ISELIN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the …
Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health
GlobeNewswire
·
April 8, 2025
WASHINGTON, D.C., April 08, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced the signing …
FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics
GlobeNewswire
·
April 8, 2025
HOUSTON, April 08, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”) , a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and potential cures for chronic diseases …
Hydreight Technologies Partners with Renowned Endocrinologist Dr. Franklin Joseph to Bring Globally Successful Weight Loss Brand to the U.S. via VSDHOne Platform
GlobeNewswire
·
April 8, 2025
VANCOUVER, British Columbia and LAS VEGAS, April 08, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a fast-growing digital health platform transforming mobile and telehealth services in the U.S., is thrilled to …
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)
GlobeNewswire
·
April 8, 2025
SANUWAVE is pleased to announce preliminary revenues of $9.1 million to $9.3 million for the first quarter ended March 31, 2025. This represents the highest Q1 quarterly revenues in Company history. Q1 2025 revenue increased between 57% and 61% compared to …
3D Bioprinting Market Worth US$2.4 billion | MarketsandMarkets™.
GlobeNewswire
·
April 8, 2025
Delray Beach, FL, April 08, 2025 (GLOBE NEWSWIRE) -- 3D Bioprinting Market, valued at US$1.2 billion in 2023, is forecasted to grow at a robust CAGR of 12.7%, reaching US$1.3 billion in 2024 and an impressive US$2.4 billion by 2029 according to a published …
Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.
GlobeNewswire
·
April 8, 2025
CINCINNATI, April 08, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) (formerly Blue Water Biotech Inc.) and Ocuvex Therapeutics, Inc. (“Ocuvex”), a privately held biopharmaceutical company focused on the development …
Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain
GlobeNewswire
·
April 8, 2025
Company on track to commence U.S. clinical studies in 2025 to support a De Novo application for FDA approval THE WOODLANDS, TX, April 08, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device …
Biotricity Recognized by Financial Times as One of 2025’s Fastest-Growing Companies in the Americas, Growing 256.4% Over the Period Analyzed
GlobeNewswire
·
April 8, 2025
REDWOOD CITY, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY) a leading Technology-as-a-Service (Taas) company specializing in cutting-edge diagnostic and chronic disease management solutions for healthcare providers and consumers, …
Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals
GlobeNewswire
·
April 8, 2025
CORAL GABLES, Fla., April 08, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …
OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System
GlobeNewswire
·
April 8, 2025
WARSAW, Ind., April 08, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the U.S. launch of the new VerteGlide …
SCIENTURE announces the divestiture of its legacy subsidiaries for a total consideration of $5 million and dedicates its full focus to the Branded and Specialty Pharma segment through Scienture, LLC.
GlobeNewswire
·
April 8, 2025
TAMPA, FL, April 08, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers …
Ocugen to Present at the 2025 Cell & Gene Meeting on the Med
GlobeNewswire
·
April 8, 2025
MALVERN, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer, …